PubMed Health⌕ Search

Biomedical subjects

Jane S Hocking

Publications and source records attributed to Jane S Hocking.

8 recordsLinked to original sources
PubMed2006

Postal surveys of physicians gave superior response rates over telephone interviews in a randomized trial.

BACKGROUND AND OBJECTIVES: To compare general practitioner (GP) response to a telephone interview with response to a postal survey with three reminders in a randomized controlled trial. METHODS: GPs were randomly assigned to either a telephone interview or a postal survey. GPs in the telephone group were mailed a letter of invitation and asked to undertake a telephone interview. GPs in the postal group were mailed a letter of invitation and questionnaire. Non-responders were sent up to three reminders, the final by registered post. Response rates were calculated for each group. RESULTS: 416 GPs were randomized to the telephone interview and 451 to the postal survey. Eighty-six in the telephone group and 30 in the postal were ineligible. One hundred thirty-four GPs completed the telephone interview with a response rate of 40.6% (95% confidence interval [CI]: 35.3%, 46.1%). Two hundred fifty-two GPs completed the postal survey with a response rate of 59.9% (95%CI: 55.0%, 64.6%). The difference in response was 19.3% (95%CI: 12.2%, 26.3%). CONCLUSIONS: These results show that postal surveys with three reminders can have superior response rates compared with a telephone interview.

Attitude of Health Personnel↗
PubMed2006

Antibiotic consumption and chlamydia prevalence in international studies.

BACKGROUND: To determine whether there is an ecological association between antibiotic use and chlamydia prevalence. METHODS: A systematic review was undertaken of international studies on chlamydia prevalence among women aged 15-25 years published between 2000 and 2005. Preference was given to studies using nucleic acid testing and representative population-based sampling methods. Data were obtained on per capita antibiotic consumption according to the defined daily dose. RESULTS: For the 12 countries for which both antibiotic consumption and relevant prevalence data for chlamydia were available, a non-significant negative correlation was found between total antibiotic consumption per capita and chlamydia prevalence among younger women according to country (r(s) = -0.242, P = 0.449). When an outlier (from the Netherlands) was excluded, the correlation was significant (r(s) = -0.615, P = 0.044). Combined use of tetracyclines and macrolides was also associated with lower chlamydia prevalence (r(s) = -0.697, P = 0.017). CONCLUSIONS: It is possible that antibiotics used for other reasons may have unexpectedly reduced the prevalence of chlamydia.

Adolescent↗
PubMed2006

A chlamydia prevalence survey of young women living in Melbourne, Victoria.

BACKGROUND: To estimate the population-based chlamydia prevalence among women aged 18 to 35 years living in Melbourne, Victoria, and to assess the feasibility of using mailed urine specimens to test women. METHODS: A simple random sample of 11,001 households in Melbourne was selected from the telephone directory. Participants completed telephone interviews and provided urine specimens through the mail for chlamydia testing. Urines were tested using polymerase chain reaction. RESULTS: 11,001 households were contacted, with 1532 households identified as including eligible women; telephone interviews were completed, with 979 women giving a response rate of 64%. Six hundred and fifty-seven women provided a urine specimen with a response rate of 43%. Among sexually active women aged 18-24 years, the chlamydia prevalence was 3.7% (95% CI: 1.2%, 8.4%) and 0.2% (95% CI: 0.0%, 1.1%) among 25-35 year olds. Chlamydia prevalence increased significantly with an increasing number of male sexual partners. CONCLUSIONS: This is the first study of its kind in Australia and shows that chlamydia prevalence increases with an increasing number of male sexual partners in the last 12 months. Mailed urine specimens are feasible for conducting population-based chlamydia-prevalence surveys but it is difficult to obtain high response rates with this methodology. Public health resources should now be directed towards investigating how to reach young women at increased risk of infection, ensuring that they are tested for chlamydia.

Adolescent↗
PubMed2006

Chlamydia testing in general practice - a survey of Victorian general practitioners.

BACKGROUND: To assess the current chlamydia testing practices of Victorian general practitioners (GPs). METHODS: GPs were randomly selected from the Australasian Medical Publishing Company's national database of medical practitioners and mailed a letter of invitation asking them to complete a postal survey. Up to three postal reminders were sent to non-responders. RESULTS: Of 421 eligible GPs, 252 (60%) returned a completed survey; 22.9% (95% CI: 17.8%, 28.6%) reported testing at least some asymptomatic patients for chlamydia each week and 26.8% (95% CI: 21.4%, 32.7%) reported that they presumptively treated patients for chlamydia without testing them at least half the time. The majority knew the appropriate specimens for diagnosing chlamydia, but 6-8% thought blood and 6% indicated that the Pap smear could be used to reliably diagnose chlamydia infection. CONCLUSIONS: These findings have implications for the future chlamydia screening pilot program in Australia and indicate that a comprehensive education program will be necessary to inform GPs and equip them with the skills to appropriately test for chlamydia in their practice.

Adult↗
PubMed2003

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

BACKGROUND: Having a family history of breast cancer, particularly if it involves early-onset disease, is a risk factor for breast cancer, but little is known about specific causes of this association. Consequently, we studied mothers, sisters, and aunts of an age-stratified sample of 1567 unselected case patients diagnosed with breast cancer before age 60 years, recruited to a population-based, case-control-family study, in which case patients, control subjects, and their relatives were administered the same questionnaire. METHODS: Extensive BRCA1 and BRCA2 mutation testing was carried out for 788 case patients diagnosed before age 40 years, including manual sequencing of DNA from 72 patients with two or more affected relatives. Standardized morbidity ratios, age-specific cumulative risks, and hazard ratios were calculated for groupings of relatives. RESULTS: Cumulative risks of breast cancer to age 50 years in the sisters, mothers, and aunts of the case patients, respectively, were 6, 3, and 2 times the population risk if the case patient was younger than age 40 years at diagnosis but were considerably lower if the case patient was older at diagnosis. When relatives of the case patients with a BRCA1 or BRCA2 mutation were excluded, these risks fell by, at most, 20%. Sisters and aunts, but not mothers, who had an additional first-degree relative with breast cancer were at increased risk, and the risk was greater when that relative was younger at diagnosis. Hazard ratios were 10.7 (95% confidence interval [CI] = 4.2 to 26.8) for sisters and 4.2 (95% CI = 2.2 to 8.1) for aunts, if the relative was aged 40 years at diagnosis. Fewer than one-third of the excess of breast cancers in relatives of case patients diagnosed before age 40 years that are attributed to familial factors are BRCA1- or BRCA2-related. CONCLUSION: Mutations in genes other than BRCA1 and BRCA2 may be associated with a high risk of breast cancer, especially in young women.

Adult↗